Stockreport

1 Reason Why I'd Hold This Weight-Loss Drug Leader Through Any Market Crash [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are locked in a battle around GLP-1 weight-loss drugs. It is a huge potential market, and the new class of drugs is v [Read more]